Matches in Wikidata for { <http://www.wikidata.org/entity/Q74271808> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q74271808 description "clinical trial" @default.
- Q74271808 description "ensayu clínicu" @default.
- Q74271808 description "klinisch onderzoek" @default.
- Q74271808 description "клінічне випробування" @default.
- Q74271808 name "Sorafenib Plus TACE Versus Sorafenib Alone as Postoperative Adjuvant Treatment for Resectable Primary Advanced HCC" @default.
- Q74271808 name "Sorafenib Plus TACE Versus Sorafenib Alone as Postoperative Adjuvant Treatment for Resectable Primary Advanced HCC" @default.
- Q74271808 type Item @default.
- Q74271808 label "Sorafenib Plus TACE Versus Sorafenib Alone as Postoperative Adjuvant Treatment for Resectable Primary Advanced HCC" @default.
- Q74271808 label "Sorafenib Plus TACE Versus Sorafenib Alone as Postoperative Adjuvant Treatment for Resectable Primary Advanced HCC" @default.
- Q74271808 prefLabel "Sorafenib Plus TACE Versus Sorafenib Alone as Postoperative Adjuvant Treatment for Resectable Primary Advanced HCC" @default.
- Q74271808 prefLabel "Sorafenib Plus TACE Versus Sorafenib Alone as Postoperative Adjuvant Treatment for Resectable Primary Advanced HCC" @default.
- Q74271808 P1050 Q74271808-7A597B1C-EFF9-410E-9EAF-8B2A1F461E06 @default.
- Q74271808 P1132 Q74271808-757B25D8-1022-4025-BF83-A9BE104086D2 @default.
- Q74271808 P1476 Q74271808-295C33C2-C09F-4BFE-949B-98AB53CDF9DF @default.
- Q74271808 P1813 Q74271808-104C5068-938F-4374-9941-4CCC4F0060C6 @default.
- Q74271808 P2899 Q74271808-FEC0A87A-F1DD-494C-A02F-816C02AB845E @default.
- Q74271808 P3098 Q74271808-9DBCFBC8-6C82-4568-A901-C9F53809C7F2 @default.
- Q74271808 P31 Q74271808-C84213D7-1143-4EE5-A842-F96802BFD042 @default.
- Q74271808 P4135 Q74271808-D6C64784-F98E-4D6F-B197-49E45C702014 @default.
- Q74271808 P580 Q74271808-17A35540-39D7-4E7A-877B-ABA85BABA891 @default.
- Q74271808 P582 Q74271808-B7E9693C-EEDF-4A21-AE87-8E1E4388B5F2 @default.
- Q74271808 P6099 Q74271808-85679924-85C4-481A-8219-A656C0F17FCC @default.
- Q74271808 P8363 Q74271808-1B70EC2E-87DB-4F26-AE9D-0A01A3638367 @default.
- Q74271808 P1050 Q33525 @default.
- Q74271808 P1132 "+158" @default.
- Q74271808 P1476 "Sorafenib Plus Transarterial Chemoembolization Versus Sorafenib Alone as Postoperative Adjuvant Treatment for Resectable Primary Advanced Hepatocellular Carcinoma: A Phase 3, Multicenter, Randomized Controlled Trial" @default.
- Q74271808 P1813 "SOURCE" @default.
- Q74271808 P2899 "+18" @default.
- Q74271808 P3098 "NCT04143191" @default.
- Q74271808 P31 Q30612 @default.
- Q74271808 P4135 "+75" @default.
- Q74271808 P580 "2019-09-15T00:00:00Z" @default.
- Q74271808 P582 "2021-09-15T00:00:00Z" @default.
- Q74271808 P6099 Q42824827 @default.
- Q74271808 P8363 Q78089383 @default.